Literature DB >> 11872260

Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro.

Sermin Genc1, Mustafa Akhisaroglu, Filiz Kuralay, Kursad Genc.   

Abstract

Recently, we have reported that erythropoietin (Epo) provides neuroprotection in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-induced neurotoxicity in vivo. In the present study, we investigated the effects of single Epo administration on brain antioxidant enzyme (superoxide dismutase (SOD) and glutathion peroxidase (GSHPx)) activities in this model in C57BL/6 mice. We found that MPTP treatment decreased GSHPx activity in both substantia nigra and striatum, and Epo restores nigral GSHPx activity decreased by MPTP. SOD enzyme activity was not significantly changed by MPTP and Epo treatment. Further, Epo stimulated astroglial GSHPx production in neonatal murine astroglial cell culture suggesting that the possible cell source for the stimulation of GSHPx activity by Epo in the MPTP-induced neurotoxicity model are astroglia. In conclusion, modulation of the astroglial antioxidant defense system might be one of the mechanisms by which Epo exerts a beneficial effect in MPTP-induced Parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872260     DOI: 10.1016/s0304-3940(02)00041-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  30 in total

1.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

2.  Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina.

Authors:  Q Wang; F Pfister; A Dorn-Beineke; F vom Hagen; J Lin; Y Feng; H P Hammes
Journal:  Diabetologia       Date:  2010-03-26       Impact factor: 10.122

3.  Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats.

Authors:  Ensari Guneli; Zahide Cavdar; Huray Islekel; Sulen Sarioglu; Serhat Erbayraktar; Muge Kiray; Selman Sokmen; Osman Yilmaz; Necati Gokmen
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

4.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

5.  Safety of intravitreally administered recombinant erythropoietin (an AOS thesis).

Authors:  James C Tsai
Journal:  Trans Am Ophthalmol Soc       Date:  2008

6.  A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants.

Authors:  Robin K Ohls; Robert D Christensen; Beena D Kamath-Rayne; Adam Rosenberg; Susan E Wiedmeier; Mahshid Roohi; Conra Backstrom Lacy; Diane K Lambert; Jill J Burnett; Barbara Pruckler; Ron Schrader; Jean R Lowe
Journal:  Pediatrics       Date:  2013-06-17       Impact factor: 7.124

Review 7.  Erythropoietin in spinal cord injury.

Authors:  Georgios K Matis; Theodossios A Birbilis
Journal:  Eur Spine J       Date:  2008-11-22       Impact factor: 3.134

8.  Hypoxia inducible factor-1alpha mediates protective effects of ischemic preconditioning on ECV-304 endothelial cells.

Authors:  Liu-Bin Shi; Jian-Hua Huang; Bao-San Han
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

Review 9.  Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.

Authors:  Anna-Leena Sirén; Theresa Fasshauer; Claudia Bartels; Hannelore Ehrenreich
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

10.  Effects of long-acting erythropoietin analog darbepoetin-α on adriamycin-induced chronic nephropathy.

Authors:  Abdelaziz M Hussein; Mohamed Eldosoky; Ahmed Handhle; Hanaa Elserougy; Mohamed Sarhan; Mohamed A Sobh; Mahmoud El Hussiny; Eman M El Nashar
Journal:  Int Urol Nephrol       Date:  2015-12-10       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.